Seoul National University Hospital: Ovarian Neoplasms trials
The registry lists 10 Ovarian Neoplasms studies with Seoul National University Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 2Phase 3 2Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian CancerNot yet recruitingNCT07273396Phase 1/2
- Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic CancerRecruitingNCT06977594Not applicable
- Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian CancerRecruitingNCT05431530
- PARP Inhibitor Oral Maintenance in Low-Risk Ovarian CancerNot yet recruitingNCT05187208Phase 4
- Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)RecruitingNCT04678102Phase 1
- Safety of Genexol PM and Carboplatin as First-line Therapy in Ovarian CancerCompletedNCT05300828
- Survival Impact of Internal Mammary or Supraclavicular LymphadenectomyCompletedNCT05005650
- High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral NeuropathyActive, not recruitingNCT04201561Phase 3
- Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal CancerStatus unknownNCT03693248Phase 3
- Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer PatientsStatus unknownNCT03509246Phase 2